Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Neurology
•
General Neurology
How do you approach treatment of eustachian tube dysfunction?
Related Questions
Can bleeding risk when switching from VKA treatment to a NOAC in frail, elderly patients be accurately compared if individual times in therapeutic range while on VKA treatment are not captured?
Would you change an elderly, frail patient with atrial fibrillation who is already on a NOAC to VKA treatment?
Do you think that home INR monitoring is a feasible option for elderly, frail patients with atrial fibrillation on VKA treatment, given variations in socioeconomic status and access to care?
Do you consider bleeding risk in elderly, frail patients with atrial fibrillation to be similar for all NOACs?
How would you treat a patient with necrotizing myopathy with positive anti-HMHCoR Ab unresponsive to standard therapies?
Do you typically load DAPT in patients with ICAD?
What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?
How do you decide the length of a routine EEG?
When do you consider ambulatory EEG as a reasonable alternative to inpatient video EEG?
What is your approach to secondary stroke prevention in patients with atrial fibrillation and intracranial stenosis (>70%)?
